Geriatric Oncology

Top Story

Extended decitabine schedule does not benefit older patients with AML

Extended decitabine schedule does not benefit older patients with AML
March 6, 2019
In the Journals Plus

Chemoradiotherapy safe, effective for older patients with limited-stage small cell lung cancer

December 26, 2018
Older patients with limited-stage small cell lung cancer achieved similar survival outcomes after concurrent chemoradiotherapy as younger patients, according to study…
Meeting News

Risk adjustment ‘negates benefit’ of stem cell transplant for acute myeloid leukemia

December 10, 2018
SAN DIEGO — The addition of a transplant-specific comorbidity score to risk stratification appeared to negate the survival benefit of hematopoietic stem cell…
Meeting NewsPerspective

Sibling transplantation with reduced-intensity conditioning fails to improve AML outcomes

December 2, 2018
SAN DIEGO — Hematopoietic stem cell transplantation with a sibling donor after reduced-intensity busulfan/fludarabine-based regimen failed to improve outcomes…
More Headlines »
CME

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »
Video

Baseball Hall of Famer Mike Schmidt ‘paying it forward’ through campaign to support patients with cancer

September 21, 2017
More »
CME

Clinical Advances in Cutaneous T-cell Lymphoma: What You Need to Know About a Rare Malignancy

This activity is supported by an educational grant from Kyowa Kirin, Inc.

Cutaneous T-cell lymphoma (CTCL) is a rare and heterogeneous type of T-cell lymphoma that is often challenging to…
More »